InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Roivant Sciences Ltd.

ROIV Clue Score19
Bermuda Fiscal year ends March CIK 0001635088 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Eric Venker
3 Nov 2026
President & Immunovant CEO
Sold on a plan
200,000
$36.31
$7.26M
Eric Venker
28 Oct 2026
President & Immunovant CEO
Sold on a plan
200,000
$36.59
$7.32M
Eric Venker
20 Oct 2026
President & Immunovant CEO
Sold on a plan
14,144
$35.42
$500.98K
Eric Venker
20 Oct 2026
President & Immunovant CEO
Sold on a plan
185,856
$35.09
$6.52M
Meghan Fitzgerald
15 Sep 2026
Director
Sold on a plan
400
$40.45
$16.18K
Meghan Fitzgerald
15 Sep 2026
Director
Sold on a plan
4,712
$39.68
$186.97K
Melissa B, Epperly
15 Sep 2026
Director
Sold on a plan
600
$40.38
$24.23K
Melissa B, Epperly
15 Sep 2026
Director
Sold on a plan
4,338
$39.65
$172.00K
Eric Venker
23 Sep 2025
President & Immunovant CEO
Sold on a plan
611,000
$14.83
$9.06M
Eric Venker
4 Oct 2023
Chief Operating Officer
Sold on a plan
153,027
$10.11
$1.55M
Showing 250 of 304 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 440
Amendments (4/A) skipped 0
Filings about a different issuer 35
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 125
Sales at will 164
Transactions with no price 0
Shares from compensation/vesting 353,199,418
Sales filed before the plan box existed 53
History held since 17 Oct 2017